Aethlon Medical, Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Aethlon Medical, Inc. is a medical therapeutic company focused on developing immunotherapeutic technologies for oncology and infectious disease. Its lead product, the Hemopurifier, is a clinical-stage extracorporeal device designed to remove circulating disease-related targets from blood and other biologic fluids. The company’s work spans applications in cancer care, life-threatening viral infections, and organ transplantation, with a broader emphasis on addressing unmet needs in medical treatment and biodefense. Aethlon Medical combines device-based therapy and filtration science to support clinical research in areas where current options remain limited. Headquartered in San Diego, California, the company operates as a specialized player in the healthcare sector, concentrating on advanced therapeutic devices rather than broad pharmaceutical products.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. James B. Frakes M.B.A.
- Employees
- 9
- Headquarters
- San Diego, CA, United States
- Website
- www.aethlonmedical.com